ORTI-B Ortivus AB (publ)

0.1083USD1.100 SEK · STO0.00%Mkt Cap: 9.59M USDP/E: —

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and EC…

Key Statistics

Company
Market Cap9.59M USD
Enterprise Value11.95M USD
Revenue (TTM)7.52M USD
Gross Profit2.91M USD
Net Income (TTM)-2.15M USD
Revenue/Share0.10 USD
Last Price0.1083 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountrySE
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINSE0000123085
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG0.50
EV/EBITDA-6.66
EV/Revenue1.59
P/S1.28
P/B5.47
EPS (TTM)-0.03 USD
EPS (Forward)—
52W Range
0.078922% of range0.2106
52W High0.2106 USD
52W Low0.0789 USD
Profitability
Gross Margin40.33%
Oper. Margin-24.62%
EBITDA Margin-23.87%
Profit Margin-29.80%
ROE-97.60%
ROA-30.84%
ROIC-43.11%
ROCE-35.18%
Growth
Revenue Growth-1.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.48M USD
CapEx (TTM)944.23K USD
FCF Margin-34.29%
FCF Yield-26.88%
Net Debt2.36M USD
Net Debt/EBITDA-1.31
Net Debt/FCF—
Balance Sheet
Debt/Equity0.87
Current Ratio1.08
Quick Ratio0.73
Book Value/Sh0.02 USD
Cash/Share0.0075 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.86.95M
Float9.15M
Insiders72.27%
Institutions11.34%
Technical
SMA 500.1376 (-21.3%)
SMA 2000.1599 (-32.3%)
Beta0.99
S&P 52W Chg12.00%
Avg Vol (30d)7.09K
Avg Vol (10d)2.32K
Technical Indicators
RSI (14)35.4
MACD-0.0800
MACD Signal-0.0947
MACD Hist.+0.0147
BB Upper0.1195 USD
BB Middle0.1128 USD
BB Lower0.1060 USD
BB Width11.89%
ATR (14)0.0065 USD
Vol Ratio (20d)1.18x

About Ortivus (STO: ORTI-B)

›

Ortivus (STO: ORTI-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 32 employees.

The shares were at 1.100 SEK on 19 November 2026, down 3.9% over 52 weeks. Its 52-week range is 0.8020 SEK to 2.140 SEK: the price is 48.6% below the high and 37.2% above the low.

Its market capitalisation is 97.48M SEK.

Ortivus reports return on equity of -97.6%, an operating margin of -24.6% and revenue down 1.8% year over year.

Its debt exceeds its cash by 23.93M SEK, a debt-to-equity ratio of 0.87. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.